Q: I’m developing Parkinson’s disease. The symptoms are intermittent and mild, but I want to do everything I can to keep them that way. Can you let me know what ...

A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of ...

Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...